| Product Code: ETC13372949 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 1.3 Billion |
| Forecast Size (2032) | USD 1.9 Billion |
| CAGR | 5.80% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | Africa |
| Fastest Growing Region | Asia |
| Largest Segment | Newborn Screening |
| Fastest Growing Segment | Genetic Testing |
| Leading Companies | Roche, Bluebird Bio, Siemens Healthineers, Quest Diagnostics, LabCorp |

The Global Sickle Cell Anemia Testing Screening Market was estimated at USD 1.3 Billion in 2025 and is projected to reach USD 1.9 Billion by 2032, growing at a CAGR of 5.80% from 2026 to 2032.
Structural changes are redefining the Global Sickle Cell Anemia Testing Screening Market, particularly as healthcare systems focus on early diagnosis. The emphasis is on developing cost-effective and efficient testing methods that cater specifically to regions with high prevalence. This evolution is critical given the public health implications, especially in under-resourced areas where sickle cell anemia remains underdiagnosed.
The market holds particular significance across multiple sectors, especially maternal health, pediatrics, and genetic services. Countries are transforming their screening protocols to include advanced genetic testing and newborn screening initiatives. Unlike adjacent diagnostic sectors, the sickle cell anemia screening market is uniquely impacted by familial genetics and regional health policies.
This graph illustrates the annual growth rates of the Global Sickle Cell Anemia Testing Screening Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 3.83 | Navigating fluctuating raw material costs influences the availability of sickle cell testing supplies. |
| 2023 | 6.87 | As healthcare providers recognize the importance of early sickle cell screening, adoption surges. |
| 2024 | 5.92 | In North America, changing patient preferences increasingly favor comprehensive anemia testing solutions. |
| 2025 | 5.43 | Hospitals are enhancing their sickle cell screening services to meet rising patient care standards. |
| 2026 | 6.04 | Sustainability initiatives in healthcare are promoting eco-friendly practices in sickle cell testing procurement. |
| 2027 | 3.38 | Clinics are expanding their service offerings to include sickle cell anemia screening across regions. |
| 2028 | 7.07 | Telehealth platforms are integrating sickle cell screening to comply with new healthcare regulations. |
| 2029 | 4.16 | Supply chain improvements streamline the delivery of materials needed for accurate anemia testing. |
| 2030 | 5.56 | A shift towards specialized training elevates the quality of sickle cell testing in laboratories. |
| 2031 | 6.42 | Biosensor technology advancements are enhancing the accuracy of sickle cell anemia diagnostics. |
| 2032 | 6.41 | Increased investment in sickle cell research accelerates the development of testing innovations. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
Access to screening services remains a major restraint in the Global Sickle Cell Anemia Testing Screening Market, particularly in low-income regions where healthcare infrastructure is limited. For example, the estimated cost for genetic testing exceeds USD 200 in some countries, creating barriers to widespread adoption. This economic hurdle often leads to underdiagnosis and inadequate treatment options for affected populations, exacerbating health disparities.
Recent trends indicate a marked shift towards integrating technology into sickle cell testing. For instance, point-of-care testing solutions have gained traction, allowing immediate results which aid in swift clinical decisions. Siemens Healthineers launched a new portable device, enhanced with AI, designed for use in remote areas, demonstrating a commitment to improving accessibility. Another significant trend is the move towards genetic counseling and advanced molecular testing methods, with projected growth in this sector expected to exceed 10% annually from 2026 to 2032, driven by an increased emphasis on precision medicine.
The landscape for the Global Sickle Cell Anemia Testing Screening Market offers substantial future revenue opportunities, particularly in the realm of public health initiatives. Expanding newborn screening programs in countries like India, aiming to cover 30 million births annually, is a prime example of this potential. Additionally, collaborating with organizations such as the World Health Organization (WHO) could facilitate funding for advanced testing technologies, creating pathways for innovative genetic solutions. Projects focused on developing low-cost testing methods can help penetrate underserved markets, increasing accessibility and ultimately driving market growth.
Newborn Screening currently leads the Global Sickle Cell Anemia Testing Screening Market with a share of approximately 45% as of 2025. This dominant position can be attributed to its critical role in early identification before symptoms arise. Conversely, the Genetic Testing segment is the fastest-growing, anticipated to experience a CAGR of 7.6% from 2026 to 2032. This growth is propelled by rising awareness around hereditary diseases and the increasing adoption of personalized medicine.
PCR technology leads the market, comprising around 50% of the share in 2025. This dominance is largely due to its efficiency and accuracy in detecting specific genetic markers of sickle cell anemia. Hemoglobin Electrophoresis is recognized as the fastest-growing technology, projected at a CAGR of 6.8% from 2026 to 2032, driven by its cost-effectiveness and rising demand in screening programs.
Early Detection is the largest application segment, capturing a share of approximately 53% as of 2025, underscoring the urgency for prompt diagnosis to manage the disease effectively. However, Population Screening is emerging as the fastest-growing application, with a CAGR of 7.4% from 2026 to 2032. This rise reflects heightened governmental focus on large-scale screening initiatives to identify asymptomatic individuals, thus improving overall health outcomes.
Hospitals represent the largest end-use segment, holding a share of approximately 60% as of 2025, providing comprehensive care for individuals diagnosed with sickle cell anemia. In contrast, Home Testing Kits are poised to grow the fastest, projected to achieve a CAGR of 8.2% from 2026 to 2032. Consumer preference for convenience and the push for patient-centered healthcare solutions drive this trend.
Africa is the largest region in the Global Sickle Cell Anemia Testing Screening Market, accounting for nearly 40% of the global share as of 2025, driven by the high prevalence of the disease. In contrast, Asia is expected to be the fastest-growing region, with a projected CAGR of 6.5% from 2026 to 2032. This growth is fueled by increasing healthcare investments and a growing understanding of genetic disorders within the population.
Government initiatives play a crucial role in shaping the regulatory landscape of the Global Sickle Cell Anemia Testing Screening Market. These actions are pivotal for enhancing diagnostic capabilities and increasing public awareness of the disease.
As the Global Sickle Cell Anemia Testing Screening Market approaches 2032, the focus will increasingly shift towards advanced personalized medicine and genetic counseling. For instance, significant investments are expected in collaborative public health initiatives like India’s newborn screening program, which targets 30 million births annually. This prioritization of genetic testing, especially in regions with high disease prevalence, highlights an evolving understanding of the need for early intervention and tailored healthcare strategies aimed at improving patient outcomes and minimizing healthcare costs.
The market landscape is witnessing noteworthy advancements that enhance diagnostic capabilities and increase accessibility. Below are key recent developments:
The competitive environment of the Global Sickle Cell Anemia Testing Screening Market is characterized by a balance of established players and innovative newcomers. As the market matures, consolidation through strategic partnerships is expected, particularly focused on improving test efficacy and reaching underserved populations.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Roche | Extensive experience in diagnostics and strong R&D capabilities. | Enhancing accessibility to screening through mobile health solutions. |
| Bluebird Bio | Pioneering gene therapy solutions for hemoglobin disorders. | Integrating genetic therapies with screening initiatives. |
| Siemens Healthineers | Leading technology in diagnostic imaging and instruments. | Focus on innovative point-of-care solutions for timely diagnostics. |
| Quest Diagnostics | Robust testing infrastructure and a broad test menu. | Streamlining genetic testing for hemoglobinopathies. |
| LabCorp | Comprehensive lab services with extensive geographic coverage. | Enhancing partnerships for better screening accessibility. |
As new technologies and therapies emerge, the need for strategic positioning will intensify, encouraging a shift towards more collaborative and innovative approaches to tackle sickle cell anemia.
Global Sickle Cell Anemia Testing Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Sickle Cell Anemia Testing Screening Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Sickle Cell Anemia Testing Screening Market Revenues & Volume, 2022 & 2032F |
3.3 Global Sickle Cell Anemia Testing Screening Market - Industry Life Cycle |
3.4 Global Sickle Cell Anemia Testing Screening Market - Porter's Five Forces |
3.5 Global Sickle Cell Anemia Testing Screening Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Sickle Cell Anemia Testing Screening Market Revenues & Volume Share, By Test Type, 2022 & 2032F |
3.7 Global Sickle Cell Anemia Testing Screening Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.8 Global Sickle Cell Anemia Testing Screening Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.9 Global Sickle Cell Anemia Testing Screening Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 Global Sickle Cell Anemia Testing Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Sickle Cell Anemia Testing Screening Market Trends |
6 Global Sickle Cell Anemia Testing Screening Market, 2022-2032 |
6.1 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Newborn Screening, 2022-2032 |
6.1.3 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Genetic Testing, 2022-2032 |
6.1.4 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Blood Test, 2022-2032 |
6.1.5 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Imaging Tests, 2022-2032 |
6.2 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Technology, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By PCR, 2022-2032 |
6.2.3 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By ELISA, 2022-2032 |
6.2.4 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Hemoglobin Electrophoresis, 2022-2032 |
6.2.5 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By MRI, 2022-2032 |
6.3 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Application, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Early Detection, 2022-2032 |
6.3.3 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Prenatal Testing, 2022-2032 |
6.3.4 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Carrier Screening, 2022-2032 |
6.3.5 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Symptomatic Patients, 2022-2032 |
6.3.6 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Population Screening, 2022-2032 |
6.4 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By End Use, 2022-2032 |
6.4.1 Overview & Analysis |
6.4.2 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Hospitals, 2022-2032 |
6.4.3 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Clinics, 2022-2032 |
6.4.4 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Research Labs, 2022-2032 |
6.4.5 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Diagnostic Centers, 2022-2032 |
6.4.6 Global Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Home Testing Kits, 2022-2032 |
7 North America Sickle Cell Anemia Testing Screening Market, Overview & Analysis |
7.1 North America Sickle Cell Anemia Testing Screening Market Revenues & Volume, 2022-2032 |
7.2 North America Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
7.3 North America Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
7.4 North America Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Technology, 2022-2032 |
7.5 North America Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Application, 2022-2032 |
7.6 North America Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By End Use, 2022-2032 |
8 Latin America (LATAM) Sickle Cell Anemia Testing Screening Market, Overview & Analysis |
8.1 Latin America (LATAM) Sickle Cell Anemia Testing Screening Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
8.4 Latin America (LATAM) Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Technology, 2022-2032 |
8.5 Latin America (LATAM) Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Application, 2022-2032 |
8.6 Latin America (LATAM) Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By End Use, 2022-2032 |
9 Asia Sickle Cell Anemia Testing Screening Market, Overview & Analysis |
9.1 Asia Sickle Cell Anemia Testing Screening Market Revenues & Volume, 2022-2032 |
9.2 Asia Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
9.2.2 China Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
9.3 Asia Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
9.4 Asia Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Technology, 2022-2032 |
9.5 Asia Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Application, 2022-2032 |
9.6 Asia Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By End Use, 2022-2032 |
10 Africa Sickle Cell Anemia Testing Screening Market, Overview & Analysis |
10.1 Africa Sickle Cell Anemia Testing Screening Market Revenues & Volume, 2022-2032 |
10.2 Africa Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
10.3 Africa Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
10.4 Africa Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Technology, 2022-2032 |
10.5 Africa Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Application, 2022-2032 |
10.6 Africa Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By End Use, 2022-2032 |
11 Europe Sickle Cell Anemia Testing Screening Market, Overview & Analysis |
11.1 Europe Sickle Cell Anemia Testing Screening Market Revenues & Volume, 2022-2032 |
11.2 Europe Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
11.2.3 France Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
11.3 Europe Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
11.4 Europe Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Technology, 2022-2032 |
11.5 Europe Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Application, 2022-2032 |
11.6 Europe Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By End Use, 2022-2032 |
12 Middle East Sickle Cell Anemia Testing Screening Market, Overview & Analysis |
12.1 Middle East Sickle Cell Anemia Testing Screening Market Revenues & Volume, 2022-2032 |
12.2 Middle East Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Sickle Cell Anemia Testing Screening Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Test Type, 2022-2032 |
12.4 Middle East Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Technology, 2022-2032 |
12.5 Middle East Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By Application, 2022-2032 |
12.6 Middle East Sickle Cell Anemia Testing Screening Market, Revenues & Volume, By End Use, 2022-2032 |
13 Global Sickle Cell Anemia Testing Screening Market Key Performance Indicators |
14 Global Sickle Cell Anemia Testing Screening Market - Export/Import By Countries Assessment |
15 Global Sickle Cell Anemia Testing Screening Market - Opportunity Assessment |
15.1 Global Sickle Cell Anemia Testing Screening Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Sickle Cell Anemia Testing Screening Market Opportunity Assessment, By Test Type, 2022 & 2032F |
15.3 Global Sickle Cell Anemia Testing Screening Market Opportunity Assessment, By Technology, 2022 & 2032F |
15.4 Global Sickle Cell Anemia Testing Screening Market Opportunity Assessment, By Application, 2022 & 2032F |
15.5 Global Sickle Cell Anemia Testing Screening Market Opportunity Assessment, By End Use, 2022 & 2032F |
16 Global Sickle Cell Anemia Testing Screening Market - Competitive Landscape |
16.1 Global Sickle Cell Anemia Testing Screening Market Revenue Share, By Companies, 2025 |
16.2 Global Sickle Cell Anemia Testing Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here